Pliant Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -264 | -365 | ||
EBITDA | -22,171 | -19,776 | -23,076 | -23,082 |
EBIT | -22,371 | -20,040 | -23,441 | -23,518 |
Net Income | -22,371 | -20,040 | -23,577 | -26,301 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,797 | -19,229 | -17,788 | -21,081 |
Cash | 24,883 | 22,190 | 45,445 | 93,732 |
Basic Shares | 61,919 | 61,803 | 61,366 | 61,406 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,580 | $9,685 |
Gross Profit | -1,696 | -2,125 | 1,580 | 9,685 |
EBITDA | -145,089 | -205,155 | -158,228 | -118,849 |
EBIT | -146,785 | -207,280 | -160,069 | -122,530 |
Net Income | -149,344 | -210,304 | -161,336 | -123,321 |
Net Change In Cash | 0 | 0 | 1,580 | 9,685 |
Cost of Revenue | -17,981 | |||
Free Cash Flow | -128,710 | -159,351 | -117,282 | -96,391 |
Cash | 45,445 | 71,188 | 63,234 | 33,685 |
Basic Shares | 61,366 | 60,538 | 58,719 | 42,015 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.36 |
2026-03-31 | -$0.32 |
2025-12-31 | -$0.35 |
2025-09-30 | -$0.43 |